Trends in Nanopharmaceutical Patents

被引：5
作者：
Antunes, Adelaide [1 ,2 ]
Fierro, Iolanda [1 ]
Guerrante, Rafaela [1 ]
Mendes, Flavia [2 ]
Alencar, Maria Simone de M. [3 ]
机构：
[1] Natl Inst Ind Property Brazil, Rio De Janeiro, Brazil
[2] Univ Fed Rio de Janeiro, Postgrad Program Technol Chem & Biochem Proc, Rio De Janeiro, Brazil
[3] Fundacao Oswaldo Cruz, Inst Sci & Technol Commun & Informat Hlth, BR-21045360 Rio De Janeiro, Brazil
来源：
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES | 2013年 / 14卷 / 04期
关键词：
health; patents; nanotechnology; pharmaceutical;
D O I：
10.3390/ijms14047016
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Investment in nanotechnology is now a given constant by governments, research centers and companies in both more developed countries and emerging markets. Due to their characteristics, such as high stability, ability to enable antigen identification on specific cells in the human body and controlling the release of drugs and, therefore, improving therapies, nanoparticles have been the subject of research and patent applications in the pharmaceutical field. According to the Organization for Economic Co-operation and Development (OCDE), patent data can be used as a source of information in order to measure science and technology activities. Thereby, this paper presents an analysis based on patent documents related to nanotechnology in the pharmaceutical sector. As a result, the analysis of patents demonstrate primarily that nanobiotechnology attracts high levels of R&D investments, including nanoparticle-based chemotherapeutic agents/drugs, monoclonal antibody nanoparticle complexes and their role in drug delivery or contrast agents with non-toxic effects.
引用
收藏
页码：7016 / 7031
页数：16
相关论文
共 43 条
[31]  
Nel A. E., 2008, Assessing the Toxic Potential of Nanomaterials, Patent No. [WO/2008/010843, 2008010843]
[32]  
Nguyen D., 2010, Patent No. [WO/2010/062322, 2010062322]
[33]  
Ryde N. P., 2010, Reduction of Flake-like Aggregation in Nanoparticulate Active Agent Compositions, Patent No. [WO/2010/138539, 2010138539]
[34]   The present and future of nanotechnology in human health care [J].
Sahoo, S. K. ;
Parveen, S. ;
Panda, J. J. .
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2007, 3 (01) :20-31
[35]  
Schmidt SR, 2009, IDRUGS, V12, P284
[36]  
Sung H., 2011, U.S. Patent, Patent No. [7863259, 78632594]
[37]  
TRIEU V, 2010, Combinations and modes of administration of therapeutic agents and combination therapy, Patent No. 2010068925
[38]  
Van Bommel T., 2005, Ultrasound Contrast Agents for Molecular Imaging, Patent No. [WO/2005/070473, 2005070473]
[39]  
Weiss S., 2006, U.S. Patent, Patent No. [2006/003464, 2006003464]
[40]  
Willard N.P., 2006, Ultrasound Contrast Agents for Molecular Imaging, Patent No. [WO/2006/054240, 2006054240]
12345